rs1555798140

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_005619.5(RTN2):​c.770A>C​(p.Asp257Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000481 in 1,456,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

RTN2
NM_005619.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.972

Publications

0 publications found
Variant links:
Genes affected
RTN2 (HGNC:10468): (reticulon 2) This gene belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. Reticulon proteins also play an important role in the replication of positive-strand RNA (ssRNA) viruses. Mutations at this locus have been associated with autosomal dominant spastic paraplegia-12. [provided by RefSeq, Aug 2020]
PPM1N (HGNC:26845): (protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)) Predicted to enable metal ion binding activity and protein serine/threonine phosphatase activity. Predicted to be involved in negative regulation of I-kappaB kinase/NF-kappaB signaling and positive regulation of canonical Wnt signaling pathway. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.059215516).
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.00000481 (7/1456794) while in subpopulation EAS AF = 0.000176 (7/39698). AF 95% confidence interval is 0.000082. There are 0 homozygotes in GnomAdExome4. There are 2 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTN2NM_005619.5 linkc.770A>C p.Asp257Ala missense_variant Exon 4 of 11 ENST00000245923.9 NP_005610.1 O75298-1A8K7F2Q6GMT0
RTN2NM_206900.3 linkc.770A>C p.Asp257Ala missense_variant Exon 4 of 10 NP_996783.1 O75298-2A8K7F2Q6GMT0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTN2ENST00000245923.9 linkc.770A>C p.Asp257Ala missense_variant Exon 4 of 11 1 NM_005619.5 ENSP00000245923.3 O75298-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000481
AC:
7
AN:
1456794
Hom.:
0
Cov.:
31
AF XY:
0.00000276
AC XY:
2
AN XY:
724812
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111966
Other (OTH)
AF:
0.00
AC:
0
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 13, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.080
T;.
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.51
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.50
T;T
M_CAP
Benign
0.0098
T
MetaRNN
Benign
0.059
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.63
N;N
PhyloP100
0.97
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.60
N;N
REVEL
Benign
0.021
Sift
Benign
0.056
T;T
Sift4G
Benign
0.48
T;T
Polyphen
0.0020
B;B
Vest4
0.12
MutPred
0.26
Loss of disorder (P = 0.0808);Loss of disorder (P = 0.0808);
MVP
0.068
MPC
0.34
ClinPred
0.069
T
GERP RS
2.4
Varity_R
0.050
gMVP
0.24
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555798140; hg19: chr19-45997468; API